Pill Connect

Objective medication adherence for clinical trials

Manchester, United Kingdom

Pill Connect is a medtech company that has developed a smart pill dispenser and software ecosystem to address medication non-adherence, primarily within clinical trials and for vulnerable individuals.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Pill Connect on @MedStartr Today Pill Connect is a medtech company that has developed a smart pill dispenser and software ecosystem to address medication non-adherence, primarily within clinical trials and for vulnerable individuals. #Immunosuppression #MedicalDevices #RPM #MedMo #MedStartrVentures

https://www.medstartr.ai/s/wZK1TpmMMaM

Get Involved in Pill Connect

How We Help

Problem Statement

Medication non-adherence, particularly within clinical trials, often leads to inaccurate drug efficacy evaluations, trial delays, and poor medication management for vulnerable individuals.

Core Technology

A patented, reusable smart pill dispenser that attaches to standard pill bottles and connects to a mobile app and cloud analytics platform.

Key Differentiators

Patented, reusable device that attaches to standard pill bottles; Records real-time dispensing data; Integrated ecosystem of hardware, mobile app, and cloud analytics

Clinical Focus

Clinical Trials; Medication Adherence

Company Info

Business Model: B2B
Founded: 2013
Total Funding: Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now
Website: pillconnect.com/

Disease Areas

Immunosuppression

Technologies

Smart Pill DispenserMedication AdherenceIoTDigital HealthSaMD

Clinical & IP

🔬

Clinical Validation

CE mark for radio/electrical safety (2025). ISO 8317:2015 child-resistant standards. ISO 9001 manufacturing. FDA-compliant materials. Patents granted in UK, EU, US, Japan.

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Pill Connect?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.